| Cytokeratin 20 was originally identified as IT, a low molecular weight, acidic (Type I) cytokeratin. This antibody can be used in immunohistochemistry as a marker for a restricted profile of carcinomas, including adenocarcinomas of the colon, transitional cell carcinomas of the bladder, Merkel-cell tumors of the skin, mucinous varian carcinoma, and some pancreatic carcinomas. Squamous cell carcinoma, adenocarcinomas of the lung, and breast, endometrium and neuroendocrine tumors were essentially negative. |
|
| Catalog # | C9097-29E |
| Applications | Suitable for use in Immunohistochemistry. Other applications have not been tested. |
| Recommended Dilution | Immunohistochemistry: Frozen and formalin-fixed, paraffin-embedded tissue sections. |
| Optimal dilutions to be determined by the researcher. |
| Positive Control | Adenocarcinoma of the colon |
| Expected Staining Pattern: Cytoplasmic |
| Epitope Retrieval: Required (Citrate Buffer pH 6.0) |
| Enzyme Digestion: Required (Pepsin) |
| Storage and Stability | May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
| CAS Number | n/a |
| Clone Type | Monoclonal |
| Isotype | IgG2a |
| Clone No | 6A60 |
| Host | Mouse |
| Source | Human |
| Concentration | Not determined. |
| Form | Supplied as a liquid in PBS, pH 7.4, and 1% BSA with 0.1% sodium azide. before the addition of glycerol to 40%. |
| Purity | Culture supernatant |
| Immunogen | Cytokeratin 20 isolated from human duodenal mucosa. |
| Specificity | Recognizes low molecular weight cytokeratin 20 (46kD). Shows no cross reactivity to other cytokeratin subtypes and intermediate filament types, including vimentin, desmin, glial fibrillary acidic protein and neurofilament protein |
|
| Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |